Diversity and Health Equity in Clinical Trials: Expert Panel Insights

Panelists at the Stanford Think Tank on Diversity and Health Equity in Clinical Trials share their expertise on improving healthcare research through diversity and inclusion. In this video, we bring together insightful discussions from our expert panel on various aspects of promoting diversity and health equity in clinical trials.

PANELISTS:
Andra Blomkalns, MD | Moderator
Ruth O'Hara, PhD
Harriet Van Spall, MD, MPH
Keith Norris, MD

TOPICS ADDRESSED:

How to Transform FDA for Diversity & Health Equity
Explore the perspectives of our panelists as they answer the pivotal question: "If you had the power, how would you change the FDA to promote diversity and health equity in clinical trials, and in the meantime, what would you do within the current FDA constructs?" Gain valuable insights into their views on these critical issues.

How Can Organizations Increase Diversity in Clinical Trials?
Delve into the perspectives of our panelists as they address the crucial question: "How can individual organizations, along with their leadership, investigators, researchers, and support staff, work collectively to address and reduce the lack of diversity in clinical trials?" Gain valuable insights into their views on these critical issues.

How to Secure Resources for Inclusive Clinical Research
Explore the perspectives of our panelists as they tackle the question: "How can we secure the necessary resources for advancing inclusive clinical research, given the challenges and varying career stages of individuals in academia and industry, and the essential role of resources in impactful research endeavors?" Gain valuable insights into their views on these critical issues.

How Can Industry Partners Advance Clinical Research?
Dive into the perspectives of our panelists as they answer the pivotal question: "If you had the power, how would you change the FDA to promote diversity and health equity in clinical trials, and in the meantime, what would you do within the current FDA constructs?" Gain valuable insights into their views on these critical issues.

Audience Questions Answered by Experts
Explore the perspectives of our panelists as they answer audience questions on the critical issues surrounding diversity, inclusion, and equity in clinical trials.

ABOUT STANFORD THINK TANK ON DIVERSITY AND HEALTH EQUITY IN CLINICAL TRIALS
The objective of this summit is to bridge connections between stakeholders and engage in thought-provoking discussions to address the current lack of diversity in clinical trials. By fostering collaborations, the aim is to propose innovative recommendations that can improve the enrollment of underrepresented participant populations and advance the science of diversity in clinical trials.
Join us in this critical conversation to promote health equity and drive change in clinical trial diversity. Learn from experts, share experiences, and shape best practices as we work together to create opportunities for future collaboration. Thank you to our organizers, steering committee, corporate sponsors, and Stanford sponsors for making this event possible.
Stay tuned for more valuable content on health equity and clinical research. Thank you for being part of this important conversation.

Organizers:
Eldrin F. Lewis, MD, MPH
Latha Palaniappan, MD, MS
Magali Fassiotto, PhD
Daryl Oakes, MD

Steering Committee:
Jayzona Alberto, EdD, MS
Lani Matsumura, EdM, MA
Jill Evans, MPH
Lauren Hailey, MA
Shoa L. Clarke, MD, PhD
Marco Perez, MD
Fatima Rodriguez, MD, MPH
Hannah Valantine, MD
Kenneth Mahaffy, MD
Maame Yaa A.B. Yiadom, MD, MPH
Shagufta Shaheen, MD

Corporate Sponsors:
PPD
Regeneron
Study Pages/Yuzu Labs

Stanford Sponsors:
Stanford Health Care
Stanford Emergency Medicine
Stanford Research Office
Stanford Center for Asian Health Research and Education
Stanford Cancer Institute